In-house roundup: Trump trade war uncertainty; 5G guidance not usable; Senate eligibility hearing takeaways; unitary SPC overview

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: Trump trade war uncertainty; 5G guidance not usable; Senate eligibility hearing takeaways; unitary SPC overview

Money

Managing IP rounds up the latest news and analysis from patent-focused businesses



Drugs

Trump trade war is “lose-lose situation” for IP in China and the US

With Trump blacklisting Huawei from the US, telecom companies tell Patent Strategy they are fearful that a trade war escalation will affect IP and are uncertain how to prepare for such an outcome. Read More... 

Diverging SEP guidelines will have little to no impact on negotiations say stakeholders

Reacting to the publication of new SEP licensing guidance, counsel at Audi, Philips and BSH Home Appliances explain how the documents will affect them and that they would like to see a more united direction emerge. Read more... 

Patent eligibility hearings “belied depth of opposition to Section 101 change”

Industry speakers from the Senate IP Subcommittee hearings last month tell Patent Strategy how they thought the inquiry was conducted and what needs to happen next to ensure US innovation is protected. Read more... 

Unitary SPCs: How, where and when they could work

Industry sources at the Pharmaceutical Patent Term Extension conference in Munich question the practical details of unitary SPCs, including granting procedure, enforcement, and judicial review. Read more... 





more from across site and SHARED ros bottom lb

More from across our site

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Gift this article